Jefferies Group’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-158,197
| Closed | -$13.4M | – | 2949 |
|
|
2019
Q4 | $13.4M | Buy |
158,197
+44,395
| +39% | +$2.96M | 0.1% | 166 |
|
|
2019
Q3 | $5.69M | Buy |
113,802
+63,674
| +127% | +$2.54M | 0.04% | 455 |
|
|
2019
Q2 | $1.83M | Buy |
50,128
+47,395
| +1,734% | +$1.55M | 0.01% | 968 |
|
|
2019
Q1 | $76K | Sell |
2,733
-8,082
| -75% | -$190K | ﹤0.01% | 2163 |
|
|
2018
Q4 | $207K | Sell |
10,815
-855
| -7% | -$19.9K | ﹤0.01% | 1816 |
|
|
2018
Q3 | $349K | Buy |
+11,670
| New | +$440K | ﹤0.01% | 1797 |
|
|
2017
Q2 | – | Sell |
-12,500
| Closed | -$611K | – | 2747 |
|
|
2017
Q1 | $611K | Buy |
+12,500
| New | +$570K | ﹤0.01% | 1514 |
|
|
2016
Q4 | – | Sell |
-30,808
| Closed | -$1.16M | – | 2612 |
|
|
2016
Q3 | $1.16M | Buy |
+30,808
| New | +$1.16M | 0.01% | 1210 |
|
|
2016
Q2 | – | Sell |
-9,027
| Closed | -$287K | – | 2566 |
|
|
2016
Q1 | $287K | Buy |
9,027
+6,327
| +234% | +$207K | ﹤0.01% | 1699 |
|
|
2015
Q4 | $101K | Sell |
2,700
-8,250
| -75% | -$312K | ﹤0.01% | 2055 |
|
|
2015
Q3 | $416K | Buy |
10,950
+10,517
| +2,429% | +$369K | ﹤0.01% | 1598 |
|
|
2015
Q2 | $12K | Buy |
433
+177
| +69% | +$4.93K | ﹤0.01% | 2766 |
|
|
2015
Q1 | $7K | Buy |
+256
| New | +$7.19K | ﹤0.01% | 2007 |
|
|
2014
Q1 | – | Sell |
-13,476
| Closed | -$520K | – | 2497 |
|
|
2013
Q4 | $520K | Buy |
+13,476
| New | +$482K | ﹤0.01% | 1139 |
|
Other funds holding MDCO
Jefferies Group's MDCO Position: Q1 2020 in Review
Jefferies Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 158,197 shares — an estimated $13.4M sold.
Jefferies Group first reported a position in MDCO in Q4 2013 and held it in 14 quarters. The position peaked at $13.4M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Jefferies Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Jefferies Group sold 158,197 Medicines Co shares in Q1 2020, an estimated $13.4M.
- Jefferies Group first reported a position in Medicines Co in Q4 2013 and held it in 14 quarters.
- Jefferies Group's Medicines Co position peaked at $13.4M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.